Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-01

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for cetirizine hydrochloride from Sandoz Inc, granting regulatory clearance for this generic antihistamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)